Skip to content
Mounjaro®
Off-label usePrescription only

Mounjaro®

Prescription — weekly injection pen

FDA-approved tirzepatide for type 2 diabetes, prescribed off-label for weight only at a provider's judgment.

We don’t offer this

We don't currently offer this branded product through the site. Whether GLP-1 treatment is appropriate for you — and which medication — is a decision your licensed provider makes with you during your visit. This page stays because the mechanism and safety profile are worth understanding.

See the weight loss medications we offer

How it works

Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes. It is the same molecule as Zepbound, and providers sometimes prescribe it off-label for weight management where they judge it appropriate.

Mounjaro is tirzepatide — the dual GLP-1/GIP mechanism described on the Zepbound page. Approved for type 2 diabetes; the weight-management indication belongs to Zepbound. Chemically they are the same medication.

The full mechanism

Who it’s for

A provider may consider it when

  • You have type 2 diabetes and weight is part of the picture — its approved use
  • Your provider judges the off-label use appropriate for your situation

Reasons it may not be prescribed

  • Anyone with a personal or family history of medullary thyroid carcinoma, or MEN 2 syndrome — this is a hard stop
  • Pregnancy, trying to become pregnant, or breastfeeding
  • A history of pancreatitis, without careful provider review
  • Type 1 diabetes, gastroparesis, or an active eating disorder without in-person care

These are the same checks your provider runs in the visit. If one applies, they will tell you plainly — and the medication portion of what you paid comes back automatically.

Important safety information

As with Zepbound: nausea, diarrhea, vomiting and constipation, mostly around dose increases; uncommon but serious risks include pancreatitis and gallbladder disease, plus the class boxed warning on thyroid C-cell tumors in rodents.

  • FDA prescribing information: Mounjaro (tirzepatide) injection
  • Boxed warning: thyroid C-cell tumors in rodents; contraindicated with personal or family history of MTC or MEN 2

Complete safety information is provided during your visit and with every prescription. This page is a summary, not a substitute for your provider's advice.

Questions

Mounjaro or Zepbound — what's the difference?

The same medication with two labels: Mounjaro is approved for type 2 diabetes, Zepbound for weight management. If weight is the goal, Zepbound is the on-label route; your provider and your coverage decide what makes sense.

Will I definitely be prescribed this?

No — a licensed provider reviews your health history and prescribes only if it's appropriate and safe for you. If it isn't, we'll tell you why, and the medication portion of any payment is refunded.

We don’t prescribe this.

A provider can talk through what we do offer, and be straight about what would actually help.